Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients.
Pasquale R, Fenizia F, Esposito Abate R, Sacco A, Esposito C, Forgione L, Rachiglio AM, Bevilacqua S, Montanino A, Franco R, Rocco G, Botti G, Denis MG, Morabito A, De Luca A, Normanno N. Pasquale R, et al. Among authors: forgione l. Pharmacogenomics. 2015;16(10):1135-48. doi: 10.2217/pgs.15.45. Epub 2015 Aug 7. Pharmacogenomics. 2015. PMID: 26249748
The role of circulating free DNA in the management of NSCLC.
Esposito Abate R, Pasquale R, Fenizia F, Rachiglio AM, Roma C, Bergantino F, Forgione L, Lambiase M, Sacco A, Piccirillo MC, Morabito A, Normanno N. Esposito Abate R, et al. Among authors: forgione l. Expert Rev Anticancer Ther. 2019 Jan;19(1):19-28. doi: 10.1080/14737140.2019.1548938. Epub 2018 Nov 29. Expert Rev Anticancer Ther. 2019. PMID: 30462523 Review.
EGFR mutations in lung cancer: from tissue testing to liquid biopsy.
Fenizia F, De Luca A, Pasquale R, Sacco A, Forgione L, Lambiase M, Iannaccone A, Chicchinelli N, Franco R, Rossi A, Morabito A, Rocco G, Piccirillo MC, Normanno N. Fenizia F, et al. Among authors: forgione l. Future Oncol. 2015;11(11):1611-23. doi: 10.2217/fon.15.23. Future Oncol. 2015. PMID: 26043215 Review.
Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer.
Gallo M, De Luca A, Maiello MR, D'Alessio A, Esposito C, Chicchinelli N, Forgione L, Piccirillo MC, Rocco G, Morabito A, Botti G, Normanno N. Gallo M, et al. Among authors: forgione l. Transl Lung Cancer Res. 2017 Aug;6(4):486-498. doi: 10.21037/tlcr.2017.05.07. Transl Lung Cancer Res. 2017. PMID: 28904891 Free PMC article. Review.
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies.
Rachiglio AM, Forgione L, Pasquale R, Barone CA, Maiello E, Antonuzzo L, Cassata A, Tonini G, Bordonaro R, Rosati G, Zaniboni A, Lonardi S, Ferrari D, Frassineti GL, Tamberi S, Pisconti S, Di Fabio F, Roma C, Orlandi A, Latiano T, Damato A, Tortora G, Pinto C, Normanno N. Rachiglio AM, et al. Among authors: forgione l. Cancers (Basel). 2022 Feb 18;14(4):1052. doi: 10.3390/cancers14041052. Cancers (Basel). 2022. PMID: 35205799 Free PMC article.
RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial.
Normanno N, Esposito Abate R, Lambiase M, Forgione L, Cardone C, Iannaccone A, Sacco A, Rachiglio AM, Martinelli E, Rizzi D, Pisconti S, Biglietto M, Bordonaro R, Troiani T, Latiano TP, Giuliani F, Leo S, Rinaldi A, Maiello E, Ciardiello F; CAPRI-GOIM Investigators. Normanno N, et al. Among authors: forgione l. Ann Oncol. 2018 Jan 1;29(1):112-118. doi: 10.1093/annonc/mdx417. Ann Oncol. 2018. PMID: 28950295 Free article. Clinical Trial.
45 results